These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 19431208)
1. AC biosusceptometry technique to evaluate the gastrointestinal transit of pellets under influence of prandial state. Miranda JR; Corá LA; Américo MF; Romeiro FG J Pharm Sci; 2010 Jan; 99(1):317-24. PubMed ID: 19431208 [TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal transit and disintegration of enteric coated magnetic tablets assessed by ac biosusceptometry. Corá LA; Romeiro FG; Américo MF; Oliveira RB; Baffa O; Stelzer M; Miranda JR Eur J Pharm Sci; 2006 Jan; 27(1):1-8. PubMed ID: 16188432 [TBL] [Abstract][Full Text] [Related]
3. Enteric coated magnetic HPMC capsules evaluated in human gastrointestinal tract by AC biosusceptometry. Corá LA; Romeiro FG; Paixão FC; Américo MF; Oliveira RB; Baffa O; Miranda JR Pharm Res; 2006 Aug; 23(8):1809-16. PubMed ID: 16858651 [TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical applications of AC biosusceptometry. Corá LA; Américo MF; Romeiro FG; Oliveira RB; Miranda JR Eur J Pharm Biopharm; 2010 Jan; 74(1):67-77. PubMed ID: 19482083 [TBL] [Abstract][Full Text] [Related]
5. AC biosusceptometry in the study of drug delivery. Corá LA; Romeiro FG; Stelzer M; Américo MF; Oliveira RB; Baffa O; Miranda JR Adv Drug Deliv Rev; 2005 Jun; 57(8):1223-41. PubMed ID: 15935871 [TBL] [Abstract][Full Text] [Related]
6. Pharmacomagnetography to evaluate the performance of magnetic enteric-coated tablets in the human gastrointestinal tract. Pinto LA; Corá LA; Rodrigues GS; Prospero AG; Soares GA; de Andreis U; de Arruda Miranda JR Eur J Pharm Biopharm; 2021 Apr; 161():50-55. PubMed ID: 33592280 [TBL] [Abstract][Full Text] [Related]
7. Assessment of gastrointestinal motility in renal transplant recipients by alternate current biosusceptometry. Teixeira MC; Magalhães I; Galvão PV; Souza GS; Miranda JR; Oliveira RB; Corá LA Transplant Proc; 2012 Oct; 44(8):2384-7. PubMed ID: 23026600 [TBL] [Abstract][Full Text] [Related]
8. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac. Kambayashi A; Blume H; Dressman J Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057 [TBL] [Abstract][Full Text] [Related]
9. Investigation of pH and Temperature Profiles in the GI Tract of Fasted Human Subjects Using the Intellicap(®) System. Koziolek M; Grimm M; Becker D; Iordanov V; Zou H; Shimizu J; Wanke C; Garbacz G; Weitschies W J Pharm Sci; 2015 Sep; 104(9):2855-63. PubMed ID: 25411065 [TBL] [Abstract][Full Text] [Related]
10. The influence of gastric emptying kinetics on the drug release from enteric coated pellets in fasted state: an in vitro/in vivo correlation. Stefanič M; Locatelli I; Vrečer F; Sever T; Mrhar A; Bogataj M Eur J Pharm Biopharm; 2012 Oct; 82(2):376-82. PubMed ID: 22884655 [TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of Magnetic Marker Monitoring Data to Characterize the Movement of Single Unit Dosage Forms Though the Gastrointestinal Tract Under Fed and Fasting Conditions. Hénin E; Bergstrand M; Weitschies W; Karlsson MO Pharm Res; 2016 Mar; 33(3):751-62. PubMed ID: 26553354 [TBL] [Abstract][Full Text] [Related]
13. Preparation and in vitro characterization of piroxicam enteric coated pellets using powder layering technique. Varshosaz J; Tavakoli N; Serri A Pharm Dev Technol; 2009; 14(3):305-11. PubMed ID: 19519183 [TBL] [Abstract][Full Text] [Related]
14. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy. Varum FJ; Hatton GB; Freire AC; Basit AW Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235 [TBL] [Abstract][Full Text] [Related]
15. ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability. Maurer JM; Schellekens RC; van Rieke HM; Stellaard F; Wutzke KD; Buurman DJ; Dijkstra G; Woerdenbag HJ; Frijlink HW; Kosterink JG J Control Release; 2013 Dec; 172(3):618-24. PubMed ID: 24096020 [TBL] [Abstract][Full Text] [Related]
16. [Drug delivery to the colon using novel one-step, dry-coated tablets (OSDrC)]. Sakurai M; Ozeki Y; Ando M; Okamoto H; Danjo K Yakugaku Zasshi; 2008 Jun; 128(6):951-7. PubMed ID: 18520141 [TBL] [Abstract][Full Text] [Related]
17. In-vivo gamma scintigraphic evaluation and determination of a gastro-resistant etodolac tablet in humans. Ozkan Y; Ceyhan T; Arslan N; Narin Y; Işimer A Comb Chem High Throughput Screen; 2010 Jul; 13(6):490-6. PubMed ID: 20426753 [TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal transfer: in vivo evaluation and implementation in in vitro and in silico predictive tools. Hens B; Brouwers J; Anneveld B; Corsetti M; Symillides M; Vertzoni M; Reppas C; Turner DB; Augustijns P Eur J Pharm Sci; 2014 Oct; 63():233-42. PubMed ID: 25064697 [TBL] [Abstract][Full Text] [Related]
19. Influence of compression forces on tablets disintegration by AC Biosusceptometry. Corá LA; Fonseca PR; Américo MF; Oliveira RB; Baffa O; Miranda JR Eur J Pharm Biopharm; 2008 May; 69(1):372-9. PubMed ID: 18164605 [TBL] [Abstract][Full Text] [Related]
20. Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption. Varum FJ; Merchant HA; Basit AW Int J Pharm; 2010 Aug; 395(1-2):26-36. PubMed ID: 20546855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]